Skip to content

Peabody Developmental Motor Scaling In Children With Period Duchenne Muscular Dystrophy

The Validity and Reliability of The Peabody Developmental Motor Score In Children With Preschool Duchenne Muscular Dystrophy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05990608
Enrollment
48
Registered
2023-08-14
Start date
2021-07-30
Completion date
2023-07-30
Last updated
2023-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duchenne Muscular Dystrophy (DMD)

Keywords

Duchenne Muscular Dystrophy (DMD), Peabody Developmental Motor Scales-2

Brief summary

To perform the reliability and validity study of the Peabody Developmental Motor Scale (Peabody Developmental Motor Scales-2) in children with Duchenne Muscular Dystrophy (DMD).

Interventions

OTHERPeabody Developmental Motor Scales-2, PDMS

The Peabody Developmental Engine Scales-2, PDMS, is a standardized norm-referenced test used to determine the motor skill level of children aged 0 to 6, identify delays in engine development, and determine individual needs and challenges. The 2 scalar, which allows children to evaluate rough and thin motor skills, consists of 6 sub-tests and 249 articles. The rough motor scale contains 4 sub-tests and 151 items, including reflex, equilibrium, locomotion and object manipulation. The slim motor scale consists of 2 sub-tests and 98 items, including cognition and visual-motor integration. Using the age-appropriate normal value ranges in the test manual to determine developmental stress risk and level, the coarse motor skills, slim motor skills, and general motor development are categorized as very low, low, below average, above average, high, very high.

Sponsors

Ondokuz Mayıs University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
3 Years to 5 Years
Healthy volunteers
Yes

Inclusion criteria

* for Group I: * No neurodevelopmental problems or diseases * 3-5 years old * Being able to cooperate with the instructions given by the physiotherapist. * Children who volunteered to participate in the study and whose families gave consent form will be included in the study. * for Group II: * Being diagnosed with Duchenne Muscular Dystrophy by a pediatric neurologist * 3-5 years old * Children who volunteered to participate in the study and whose parents' consent was obtained will be included in the study.

Exclusion criteria

* Children with a behavioral condition and any disorder that interferes with testing (eg autism spectrum disorder) * Failure to cooperate with the physiotherapist who made the evaluations. * Lack of volunteers.

Design outcomes

Primary

MeasureTime frame
Peabody Developmental Motor Scales-2This assessment will take place over the course of the study started and to the finish time

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026